510K Clearance

Advanced Medical Solutions Grp PLC
11 October 2006



For immediate release                                            11 October 2006

                     Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')

                FDA clears surgical skin sealant for sale in US


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, today announces that Kimberly-Clark* Integuseal*
Microbial Sealant has received 510(k) clearance by the Food & Drug
Administration (FDA) allowing it to be marketed in the US.

Kimberly-Clark* Integuseal* Microbial Sealant is used to reduce the risk of skin
flora contamination throughout a surgical procedure, a key factor in the
development of surgical site infections which occur in 2-5% of all surgical
procedures.  This can lead to serious complications and increased morbidity to
the patient and significant incremental costs to health care providers. It is
generally accepted that contamination by the patient's endogenous skin flora is
a key factor in the development of surgical site infections and despite standard
preventative steps, these remain an issue of concern.

Based upon patented cyanoacrylate technology, AMS has developed an innovative
film-forming solution that bonds to the skin sealing off the spaces where
bacteria can grow and immobilises endogenous pathogens thereby reducing the risk
of skin flora contamination.

A novel applicator has been developed that allows the solution to be effectively
applied even on irregular and contoured areas of the body, such as shoulders and
knees, which are generally difficult to drape.  Easy to apply and fast-drying,
Kimberly-Clark* Integuseal* Microbial Sealant can be used in conjunction with a
variety of preparatory treatments and surgical products such as electrocautery,
sutures, staples and wound adhesives.

In March 2006 AMS announced that it had entered into a strategic partnership
with Kimberly-Clark Health Care who would have exclusive rights to market and
distribute this technology in all global markets under its brand Kimberly-Clark*
Integuseal* Microbial Sealant.  Atlanta based Kimberly-Clark Health Care is an
over $1 billion turnover business unit within the global Kimberly-Clark
Corporation.  It manufactures and markets a wide range of surgical products and
is a leader in several medical device categories.

Commenting on today's announcement Dr. Don Evans, Chief Executive of AMS stated:

'We are delighted that Kimberly-Clark* Integuseal* Microbial Sealant has now
been cleared for sale into the US.  The product has already been cleared and
launched into the EU and other geographies and this allows entry into the
world's biggest market during 2007.

'Kimberly-Clark Health Care's strong presence and focus on infection control in
the Operating Room make  it an ideal partner for rapid commercialisation of this
exciting new technology.'

                                     -ENDS-


For further information, please contact:

Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS's technology and products currently serve the majority of the key global
markets and strategic partners.


Kimberly-Clark in the Healthcare Environment

Around the world, medical professionals turn to Kimberly-Clark for a wide
portfolio of solutions that improve the health, hygiene and well-being of their
patients and staff.  As part of their healing mission, caregivers rely on
Kimberly-Clark to deliver clinical solutions and educational resources that they
can depend on to prevent, diagnose and manage a wide variety of
healthcare-associated infections.

This over $1 billion global enterprise of Kimberly-Clark Corporation holds the
No. 1 and No. 2 market share positions in several categories including infection
control solutions, surgical solutions, pain management and digestive health. And
throughout the care continuum, patients and staff alike trust Kimberly-Clark*
medical supplies and devices, KLEENEX* tissues, KIMBERLY-CLARK* professional
skin care products, and SCOTT* towels for day-to-day needs.

For more information, please visit http://www.kchealthcare.com.

* Registered Trademark or Trademark of Kimberly-Clark Worldwide, Inc. (c) 2006
KCWW.


                      This information is provided by RNS
            The company news service from the London Stock Exchange